Details for: CTTNBP2
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 45.03rCSI 53.79%PRS 72.5
-
CSI 43.86rCSI 56.55%PRS 73.51
-
CSI 37.48rCSI 68.11%PRS 80.24
-
CSI 32.53rCSI 54.6%PRS 72.35
-
CSI 31.18rCSI 38.79%PRS 70.17
-
CSI 30.39rCSI 66.87%PRS 70.53
-
CSI 21.04rCSI 51.15%PRS 70.12
-
CSI 20.33rCSI 63.58%PRS 75.77
-
CSI 19.97rCSI 53.38%PRS 80.84
-
CSI 18.1rCSI 56.58%PRS 73.74
-
CSI 18.08rCSI 31.27%PRS 80.88
-
CSI 17.92rCSI 61.39%PRS 74.14
-
CSI 15.62rCSI 56.2%PRS 70.35
-
CSI 15.38rCSI 58.14%PRS 72.65
-
CSI 14.51rCSI 30.86%PRS 81.44
-
CSI 13.98rCSI 22.49%PRS 78.84
-
CSI 13.74rCSI 19.47%PRS 84.71
-
CSI 12.14rCSI 32.33%PRS 75.08
-
CSI 11.51rCSI 13.29%PRS 79.95
-
CSI 10.84rCSI 11.31%PRS 86.25
-
CSI 10.4rCSI 22.97%PRS 75.34
-
CSI 9.39rCSI 8.26%PRS 78.07
-
CSI 9.34rCSI 11.99%PRS 78.3
-
CSI 9.33rCSI 27.57%PRS 77.97
-
CSI 9.25rCSI 54.48%PRS 72.81
-
CSI 8.82rCSI 14.44%PRS 78.99
-
CSI 8.57rCSI 19.55%PRS 80.14
-
CSI 8.27rCSI 60.77%PRS 77.15
-
CSI 8.1rCSI 14.2%PRS 82.78
-
CSI 7.94rCSI 14.87%PRS 77.69
-
CSI 7.69rCSI 30.94%PRS 87.07
-
CSI 7.42rCSI 11.34%PRS 92.55
-
CSI 7.22rCSI 9.26%PRS 83.8
-
CSI 7.03rCSI 14.11%PRS 80.07
-
CSI 7.02rCSI 5.2%PRS 82.67
-
CSI 6.93rCSI 20.44%PRS 87.94
-
CSI 6.87rCSI 25.94%PRS 71.34
-
CSI 6.85rCSI 15.81%PRS 77.13
-
CSI 6.84rCSI 34%PRS 81.76
-
CSI 6.82rCSI 9.12%PRS 91.46
-
CSI 6.72rCSI 16.06%PRS 75.89
-
CSI 6.62rCSI 10.09%PRS 84.38
-
CSI 6.59rCSI 17.19%PRS 88.58
-
CSI 6.47rCSI 14.5%PRS 73.11
-
CSI 6.4rCSI 14.63%PRS 88.28
-
CSI 6.39rCSI 6.85%PRS 89.16
-
CSI 6.35rCSI 11.21%PRS 71.8
-
CSI 6.31rCSI 6.07%PRS 86.34
-
CSI 6.28rCSI 5.79%PRS 88.44
-
CSI 6.16rCSI 11.08%PRS 81.78
-
CSI 6.15rCSI 15.03%PRS 80.28
-
CSI 5.66rCSI 9.11%PRS 73.5
-
CSI 5.64rCSI 16.34%PRS 78.16
-
CSI 5.43rCSI 46.78%PRS 77.83
-
CSI 5.38rCSI 7.68%PRS 87.8
-
CSI 5.28rCSI 5.78%PRS 88.99
-
CSI 5.26rCSI 25.19%PRS 87.89
-
CSI 5.06rCSI 20.03%PRS 81.68
-
CSI 4.94rCSI 10.67%PRS 87.67
-
CSI 4.86rCSI 10.08%PRS 85.09
-
CSI 4.62rCSI 7.06%PRS 89.76
-
CSI 4.59rCSI 8.67%PRS 93.03
-
CSI 4.5rCSI 19.98%PRS 88.05
-
CSI 4.37rCSI 14.49%PRS 90.3
-
CSI 4.26rCSI 10.8%PRS 79.82
-
CSI 4.25rCSI 16.62%PRS 68.3
-
CSI 4.07rCSI 12.55%PRS 90.01
-
CSI 4.05rCSI 10.55%PRS 81.42
-
CSI 3.95rCSI 11.44%PRS 86.56
-
CSI 3.95rCSI 17.36%PRS 76.1
-
CSI 3.91rCSI 61.71%PRS 88.23
-
CSI 3.86rCSI 12.93%PRS 72.67
-
CSI 3.72rCSI 7.65%PRS 75.01
-
CSI 3.71rCSI 9.58%PRS 83.88
-
CSI 3.6rCSI 51.09%PRS 79.34
-
CSI 3.6rCSI 7.81%PRS 75.75
-
CSI 3.48rCSI 4.74%PRS 80.36
-
CSI 3.42rCSI 5.09%PRS 86.67
-
CSI 3.41rCSI 15.96%PRS 94.63
-
CSI 3.2rCSI 12.19%PRS 80.01
-
CSI 3.19rCSI 4.57%PRS 78.68
-
CSI 3.06rCSI 4.53%PRS 89.67
-
CSI 2.95rCSI 16.67%PRS 75.57
-
CSI 2.9rCSI 3.52%PRS 91.84
-
CSI 2.82rCSI 11.72%PRS 86.5
-
CSI 2.8rCSI 11.42%PRS 79.69
-
CSI 2.72rCSI 4.33%PRS 81.91
-
CSI 2.59rCSI 52.81%PRS 78.77
-
CSI 2.59rCSI 62.1%PRS 69.94
-
CSI 2.59rCSI 7.14%PRS 83.8
-
CSI 2.58rCSI 52.47%PRS 77.91
-
CSI 2.57rCSI 61.89%PRS 70.39
-
CSI 2.4rCSI 5.72%PRS 87.31
-
CSI 2.29rCSI 3.13%PRS 79.33
-
CSI 2.24rCSI 3.53%PRS 88.3
-
CSI 2.16rCSI 7.09%PRS 74.75
-
CSI 2.01rCSI 2.41%PRS 85.92
-
CSI 1.96rCSI 4.16%PRS 94.08
-
CSI 1.96rCSI 2.37%PRS 67.75
-
CSI 1.83rCSI 4.71%PRS 83.56
-
CSI 0.8rCSI 6.1%PRS 80.4%
-
CSI 0.8rCSI 3.3%PRS 91.9%
-
CSI 0.9rCSI 7.8%PRS 74.4%
-
CSI 1.0rCSI 6.4%PRS 82.2%
-
CSI 1.1rCSI 1.5%PRS 84.1%
-
CSI 1.2rCSI 8.4%PRS 77.7%
-
CSI 1.3rCSI 5.8%PRS 81.9%
-
CSI 1.4rCSI 3.9%PRS 83.0%
-
CSI 1.6rCSI 11.6%PRS 84.3%
-
CSI 1.7rCSI 7.4%PRS 72.6%
-
CSI 1.7rCSI 13.1%PRS 89.7%
-
CSI 1.8rCSI 9.2%PRS 77.4%
-
CSI 1.8rCSI 3.4%PRS 89.5%
-
CSI 1.8rCSI 3.2%PRS 57.5%
-
CSI 1.8rCSI 4.7%PRS 83.6%
-
CSI 2.0rCSI 2.4%PRS 67.8%
-
CSI 2.0rCSI 4.2%PRS 94.1%
-
CSI 2.0rCSI 2.4%PRS 85.9%
-
CSI 2.2rCSI 7.1%PRS 74.8%
-
CSI 2.2rCSI 3.5%PRS 88.3%
-
CSI 2.3rCSI 3.1%PRS 79.3%
-
CSI 2.4rCSI 5.7%PRS 87.3%
-
CSI 2.6rCSI 61.9%PRS 70.4%
-
CSI 2.6rCSI 52.5%PRS 77.9%
-
CSI 2.6rCSI 7.1%PRS 83.8%
-
CSI 2.6rCSI 62.1%PRS 69.9%
-
CSI 2.6rCSI 52.8%PRS 78.8%
-
CSI 2.7rCSI 4.3%PRS 81.9%
-
CSI 2.8rCSI 11.4%PRS 79.7%
-
CSI 2.8rCSI 11.7%PRS 86.5%
-
CSI 2.9rCSI 3.5%PRS 91.8%
-
CSI 3.0rCSI 16.7%PRS 75.6%
-
CSI 3.1rCSI 4.5%PRS 89.7%
-
CSI 3.2rCSI 4.6%PRS 78.7%
-
CSI 3.2rCSI 12.2%PRS 80.0%
-
CSI 3.4rCSI 16.0%PRS 94.6%
-
CSI 3.4rCSI 5.1%PRS 86.7%
-
CSI 3.5rCSI 4.7%PRS 80.4%
-
CSI 3.6rCSI 7.8%PRS 75.8%
-
CSI 3.6rCSI 51.1%PRS 79.3%
-
CSI 3.7rCSI 9.6%PRS 83.9%
-
CSI 3.7rCSI 7.7%PRS 75.0%
-
CSI 3.9rCSI 12.9%PRS 72.7%
-
CSI 3.9rCSI 61.7%PRS 88.2%
-
CSI 4.0rCSI 17.4%PRS 76.1%
-
CSI 4.0rCSI 11.4%PRS 86.6%
-
CSI 4.1rCSI 10.6%PRS 81.4%
-
CSI 4.1rCSI 12.6%PRS 90.0%
-
CSI 4.3rCSI 16.6%PRS 68.3%
-
CSI 4.3rCSI 10.8%PRS 79.8%
-
CSI 4.4rCSI 14.5%PRS 90.3%
-
CSI 4.5rCSI 20.0%PRS 88.1%
-
CSI 4.6rCSI 8.7%PRS 93.0%
-
CSI 4.6rCSI 7.1%PRS 89.8%
-
CSI 4.9rCSI 10.1%PRS 85.1%
-
CSI 4.9rCSI 10.7%PRS 87.7%
-
CSI 5.1rCSI 20.0%PRS 81.7%
-
CSI 5.3rCSI 25.2%PRS 87.9%
-
CSI 5.3rCSI 5.8%PRS 89.0%
-
CSI 5.4rCSI 7.7%PRS 87.8%
-
CSI 5.4rCSI 46.8%PRS 77.8%
-
CSI 5.6rCSI 16.3%PRS 78.2%
-
CSI 5.7rCSI 9.1%PRS 73.5%
-
CSI 6.2rCSI 15.0%PRS 80.3%
-
CSI 6.2rCSI 11.1%PRS 81.8%
-
CSI 6.3rCSI 5.8%PRS 88.4%
-
CSI 6.3rCSI 6.1%PRS 86.3%
-
CSI 6.4rCSI 11.2%PRS 71.8%
-
CSI 6.4rCSI 6.9%PRS 89.2%
-
CSI 6.4rCSI 14.6%PRS 88.3%
-
CSI 6.5rCSI 14.5%PRS 73.1%
-
CSI 6.6rCSI 17.2%PRS 88.6%
-
CSI 6.6rCSI 10.1%PRS 84.4%
-
CSI 6.7rCSI 16.1%PRS 75.9%
-
CSI 6.8rCSI 9.1%PRS 91.5%
-
CSI 6.8rCSI 34.0%PRS 81.8%
-
CSI 6.9rCSI 15.8%PRS 77.1%
-
CSI 6.9rCSI 25.9%PRS 71.3%
-
CSI 6.9rCSI 20.4%PRS 87.9%
-
CSI 7.0rCSI 5.2%PRS 82.7%
-
CSI 7.0rCSI 14.1%PRS 80.1%
-
CSI 7.2rCSI 9.3%PRS 83.8%
-
CSI 7.4rCSI 11.3%PRS 92.6%
-
CSI 7.7rCSI 30.9%PRS 87.1%
-
CSI 7.9rCSI 14.9%PRS 77.7%
-
CSI 8.1rCSI 14.2%PRS 82.8%
-
CSI 8.3rCSI 60.8%PRS 77.2%
-
CSI 8.6rCSI 19.6%PRS 80.1%
-
CSI 8.8rCSI 14.4%PRS 79.0%
-
CSI 9.3rCSI 54.5%PRS 72.8%
-
CSI 9.3rCSI 27.6%PRS 78.0%
-
CSI 9.3rCSI 12.0%PRS 78.3%
-
CSI 9.4rCSI 8.3%PRS 78.1%
-
CSI 10.4rCSI 23.0%PRS 75.3%
-
CSI 10.8rCSI 11.3%PRS 86.3%
-
CSI 11.5rCSI 13.3%PRS 80.0%
-
CSI 12.1rCSI 32.3%PRS 75.1%
-
CSI 13.7rCSI 19.5%PRS 84.7%
-
CSI 14.0rCSI 22.5%PRS 78.8%
-
CSI 14.5rCSI 30.9%PRS 81.4%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 2885792292
Symbol: CTTB2_HUMAN
Name: Cortactin-binding protein 2
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11707066
Title: Identification of the human cortactin-binding protein-2 gene from the autism candidate region at 7q31.
PubMed ID: 11707066
PubMed ID: 12853948
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 11214970
Title: Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
PubMed ID: 11214970
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
Sequence Information:
- Length: 1663
- Mass: 181051
- Checksum: 367B933A177D6E3B
- Sequence:
MATDGASCEP DLSRAPEDAA GAAAEAAKKE FDVDTLSKSE LRMLLSVMEG ELEARDLVIE ALRARRKEVF IQERYGRFNL NDPFLALQRD YEAGAGDKEK KPVCTNPLSI LEAVMAHCKK MQERMSAQLA AAESRQKKLE MEKLQLQALE QEHKKLAARL EEERGKNKQV VLMLVKECKQ LSGKVIEEAQ KLEDVMAKLE EEKKKTNELE EELSAEKRRS TEMEAQMEKQ LSEFDTEREQ LRAKLNREEA HTTDLKEEID KMRKMIEQLK RGSDSKPSLS LPRKTKDRRL VSISVGTEGT VTRSVACQTD LVTENADHMK KLPLTMPVKP STGSPLVSAN AKGSVCTSAT MARPGIDRQA SYGDLIGASV PAFPPPSANK IEENGPSTGS TPDPTSSTPP LPSNAAPPTA QTPGIAPQNS QAPPMHSLHS PCANTSLHPG LNPRIQAARF RFQGNANDPD QNGNTTQSPP SRDVSPTSRD NLVAKQLARN TVTQALSRFT SPQAGAPSRP GVPPTGDVGT HPPVGRTSLK THGVARVDRG NPPPIPPKKP GLSQTPSPPH PQLKVIIDSS RASNTGAKVD NKTVASTPSS LPQGNRVINE ENLPKSSSPQ LPPKPSIDLT VAPAGCAVSA LATSQVGAWP AATPGLNQPA CSDSSLVIPT TIAFCSSINP VSASSCRPGA SDSLLVTASG WSPSLTPLLM SGGPAPLAGR PTLLQQAAAQ GNVTLLSMLL NEEGLDINYS CEDGHSALYS AAKNGHTDCV RLLLSAEAQV NAADKNGFTP LCAAAAQGHF ECVELLISYD ANINHAADGG QTPLYLACKN GNKECIKLLL EAGTNRSVKT TDGWTPVHAA VDTGNVDSLK LLMYHRIPAH GNSFNEEESE SSVFDLDGGE ESPEGISKPV VPADLINHAN REGWTAAHIA ASKGFKNCLE ILCRHGGLEP ERRDKCNRTV HDVATDDCKH LLENLNALKI PLRISVGEIE PSNYGSDDLE CENTICALNI RKQTSWDDFS KAVSQALTNH FQAISSDGWW SLEDVTCNNT TDSNIGLSAR SIRSITLGNV PWSVGQSFAQ SPWDFMRKNK AEHITVLLSG PQEGCLSSVT YASMIPLQMM QNYLRLVEQY HNVIFHGPEG SLQDYIVHQL ALCLKHRQMA AGFSCEIVRA EVDAGFSKEQ LLDLFISSAC LIPVKQSPSK KKIIIILENL EKSSLSELLR DFLAPLENRS TESPCTFQKG NGLSECYYFH ENCFLMGTIA KACLQGSDLL VQQHFRWVQL RWDGEPMQGL LQRFLRRKVV NKFKGQAPSP CDPVCKIVDW ALSVWRQLNS CLARLGTPEA LLGPKYFLSC PVVPGHAQVT VKWMSKLWNG VIAPRVQEAI LSRASVKRQP GFGQTTAKRH PSQGQQAVVK AALSILLNKA VLHGCPLPRA ELDQHTADFK GGSFPLSIVS SYNTCNKKKG ESGAWRKVNT SPRRKSGRFS LPTWNKPDLS TEGMKNKTIS QLNCNRNASL SKQKSLENDL SLTLNLDQRL SLGSDDEADL VKELQSMCSS KSESDISKIA DSRDDLRMFD SSGNNPVLSA TINNLRMPVS QKEVSPLSSH QTTECSNSKS KTELGVSRVK SFLPVPRSKV TQCSQNTKRS SSSSNTRQIE INNNSKEVNW NLHKNEHLEK PNK